AEOLUS PHARMACEUTICALS, INC. — Revenue by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/63bb013d-5802-4b95-97eb-5ae9a5467e98/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2015 | $3.1M | 2014-10-01 – 2015-09-30 | evidence 0001102624-15-001827 |
| FY 2014 | $9.6M | 2013-10-01 – 2014-09-30 | evidence 0001102624-15-000225 |
| FY 2013 | $3.9M | 2012-10-01 – 2013-09-30 | evidence 0001102624-13-001543 |
| FY 2012 | $7.3M | 2011-10-01 – 2012-09-30 | evidence 0001102624-13-000604 |
| FY 2011 | $4.8M | 2010-10-01 – 2011-09-30 | evidence 0001102624-13-000604 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
AEOLUS PHARMACEUTICALS, INC. — all facts · Net Income · Operating Income